India GlycolsBOM:500201 +4.80%66 ROE % is 11.85% as of Mar. 2026, which is 4% above its 10-year median of 11.39. GuruFocus rates BOM:500201 with a GF Score™ of 66/100 and a GF Value™ of ₹752.37 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,585 Chemicals companies, India Glycols ranks better than 77.79% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. India Glycols's annualized net income for the quarter that ended in Mar. 2026 was ₹3,475 Mil. India Glycols's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ₹29,328 Mil. Therefore, India Glycols's annualized ROE % for the quarter that ended in Mar. 2026 was 11.85%.
The historical rank and industry rank for India Glycols's ROE % or its related term are showing as below:
BOM:500201'
s ROE % Range Over the Past 10 Years
Min: 4.77 Med: 11.39 Max: 22.96
Current: 11.58
During the past 13 years, India Glycols's highest ROE % was 22.96%. The lowest was 4.77%. And the median was 11.39%.
BOM:500201's ROE % is ranked better than 77.79% of 1585
companies
in the Chemicals industry
Industry Median: 5.2
vs BOM:500201: 11.58
India Glycols (BOM:500201) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
India Glycols ROE % Related Terms
India Glycols ROE % Historical Data
* Premium members only.
The historical data trend for India Glycols's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, India Glycols's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
India Glycols ROE % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, India Glycols's ROE % distribution charts can be found below:
* The bar in red indicates where India Glycols's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
India Glycols (BOM:500201) has a ROE % of 11.85% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on India Glycols and its competitors. This is near median its historical median of 11.39. Over the past decade, India Glycols' ROE % has ranged from 4.77 to 22.96. According to the industry distribution chart, India Glycols ranks #352 out of 1585 companies in the Chemicals industry, placing it in the top 22.2%.
Is India Glycols' ROE % too high?
India Glycols' current ROE % of 11.85% is near median its 10-year median of 11.39. Over the past 10 years, this metric has ranged from a low of 4.77 to a high of 22.96. The Chemicals industry median ROE % is 5.20. India Glycols' value of 11.85% is 127.9% above this industry median. Based on the distribution chart, India Glycols ranks #352 out of 1585 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, India Glycols has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' ROE % compare to DOW?
According to the Chemicals industry distribution chart, India Glycols ranks #352 out of 1585 companies for ROE %. This places India Glycols in the top 22% of its industry — outperforming the majority of peers. The industry median ROE % is 5.20. India Glycols' value of 11.85% is 127.9% above this benchmark. Historically, India Glycols' own ROE % has ranged from 4.77 to 22.96 over the past decade. While the company's 10-year median is 11.39 vs. the industry median of 5.20, India Glycols has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Chemicals company?
The median ROE % among Chemicals companies is 5.20, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. India Glycols's current ROE % of 11.85% is 127.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on India Glycols and its competitors. For the Chemicals industry, the median ROE % is 5.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. India Glycols's current ROE % is 11.85%, which is near median its own 10-year median of 11.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (BOM:500201) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹752.37, compared to a current price of ₹1,076.15 — trading 43% above its estimated fair value. The current ROE % is 11.85%, which is near median its 10-year median of 11.39 and 127.9% above the Chemicals industry median of 5.20. India Glycols' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For India Glycols (BOM:500201), the current ROE % is 11.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is India Glycols (BOM:500201) Overvalued in 2026?
Based on GuruFocus' analysis, India Glycols stock appears to be overvalued.
The current stock price of ₹1,076.15 is trading 43% above its estimated GF Value™ of ₹752.37.
GuruFocus considers India Glycols to be Significantly Overvalued.
Key valuation signals for BOM:500201:
ROE %: 11.85% (near median its 10-year median of 11.39)
GF Value™: ₹752.37 vs. price of ₹1,076.15 (43% above fair value)
Industry Position: 127.9% above the Chemicals median (#352 of 1585)
No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
66GF Score
Get the complete analysis for BOM:500201
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500201 has been successfully added to your 
